[go: up one dir, main page]

BR9809375A - Sais de éster de 3-sulfato 5-alfa-pregn-16-3beta-ol-20-ona com atividade progestina - Google Patents

Sais de éster de 3-sulfato 5-alfa-pregn-16-3beta-ol-20-ona com atividade progestina

Info

Publication number
BR9809375A
BR9809375A BR9809375-4A BR9809375A BR9809375A BR 9809375 A BR9809375 A BR 9809375A BR 9809375 A BR9809375 A BR 9809375A BR 9809375 A BR9809375 A BR 9809375A
Authority
BR
Brazil
Prior art keywords
pregn
3beta
alpha
sulfate
ester salts
Prior art date
Application number
BR9809375-4A
Other languages
English (en)
Inventor
Reinhold Hans Wilhelm Bender
Mahdi Bakir Fawzi
Horace Fletcher Iii
George Oscar Morton
Syed Muzafar Shah
Xuejun Tang
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9809375A publication Critical patent/BR9809375A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: <B>"SAIS DE éSTER DE 3-SULFATO 5-ALFA-PREGN-16-3BETA-OL-20-ONA COM ATIVIDADE PROGESTINA"<D>. A invenção fornece um sal farmaceuticamente aceitável de éster de 3-sulfato de 5<244>-pregn-16-en-3<225>-ol-20-ona, que é de utilidade como um agente progestacional.
BR9809375-4A 1997-05-02 1998-04-28 Sais de éster de 3-sulfato 5-alfa-pregn-16-3beta-ol-20-ona com atividade progestina BR9809375A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85056997A 1997-05-02 1997-05-02
PCT/US1998/008453 WO1998050410A1 (en) 1997-05-02 1998-04-28 Salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity

Publications (1)

Publication Number Publication Date
BR9809375A true BR9809375A (pt) 2000-07-04

Family

ID=25308514

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809375-4A BR9809375A (pt) 1997-05-02 1998-04-28 Sais de éster de 3-sulfato 5-alfa-pregn-16-3beta-ol-20-ona com atividade progestina

Country Status (15)

Country Link
EP (1) EP0980381B1 (pt)
JP (1) JP2001525805A (pt)
KR (1) KR20010012179A (pt)
CN (1) CN1255141A (pt)
AR (1) AR012635A1 (pt)
AT (1) ATE246705T1 (pt)
AU (1) AU730311B2 (pt)
BR (1) BR9809375A (pt)
CA (1) CA2289108A1 (pt)
DE (1) DE69816985T2 (pt)
DK (1) DK0980381T3 (pt)
ES (1) ES2203944T3 (pt)
PT (1) PT980381E (pt)
WO (1) WO1998050410A1 (pt)
ZA (1) ZA983685B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0104423D0 (sv) * 2001-12-27 2001-12-27 Umecrine Ab Pregnane steroids and their use in the treatment of CNS disorders

Also Published As

Publication number Publication date
EP0980381B1 (en) 2003-08-06
ES2203944T3 (es) 2004-04-16
JP2001525805A (ja) 2001-12-11
ATE246705T1 (de) 2003-08-15
KR20010012179A (ko) 2001-02-15
EP0980381A1 (en) 2000-02-23
PT980381E (pt) 2003-12-31
DE69816985T2 (de) 2004-07-22
ZA983685B (en) 1999-11-01
CN1255141A (zh) 2000-05-31
AU730311B2 (en) 2001-03-01
AU7164498A (en) 1998-11-27
WO1998050410A1 (en) 1998-11-12
CA2289108A1 (en) 1998-11-12
DK0980381T3 (da) 2003-10-27
AR012635A1 (es) 2000-11-08
DE69816985D1 (de) 2003-09-11

Similar Documents

Publication Publication Date Title
ES2159591T3 (es) Composicion de liberacion controlada.
BR9803596A (pt) Derivados do resorcinol.
TR200101859T2 (tr) Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
NO981944L (no) Lipopolyaminer som transfeksjonsmidler samt farmas÷ytisk anvendelse derav
PT797439E (pt) Utilizacao de pramipexote como agente neuroprotector
BR0107667A (pt) Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo
ES2162198T3 (es) Agentes estrogenos.
GB9514473D0 (en) Chemical compounds
BR9711194A (pt) Uso de agente quelante clioquinol para a fabricação de uma composição farmacêutica para o tratamento de doença de alzheimer.
BRPI0017528B8 (pt) uso de uma composição contendo sal de cetotifeno
BR9913225A (pt) Novos agentes antibacterianos de isoxazolinona
BR9913457A (pt) Neuroproteção
DK0998287T3 (da) Anvendelse af levobupivacain
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
BR9813817A (pt) Análogos de hemiasterlina
PT933379E (pt) Novos derivados peptidicos contendo um radical tiazolil-alanina
BR0010983A (pt) Preparações para a aplicação de agentes antiinflamatórios
BR0009211A (pt) Derivados de resorcinol
IT1318667B1 (it) Medicamento antinfiammatorio.
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
BR9812982A (pt) Agente anti-reumático
DE60121048D1 (de) PYRAZINOi1&#39;2&#39;:1,6öPYRIDOi3,4-BöINDOLDERIVATE
BR0108313A (pt) Composição farmacêutica para injeção intramuscular contendo loxoprofeno
BR9809375A (pt) Sais de éster de 3-sulfato 5-alfa-pregn-16-3beta-ol-20-ona com atividade progestina
BR0009194A (pt) Composição do resorcinol

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A, 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1971 DE 14/10/2008.